Chargement en cours...
NECTIN4: A Novel Therapeutic Target for Melanoma
Malignant melanoma is the most common lethal skin cancer and causes death in a short time when metastasized. Although BRAF inhibitors (BRAFi) have greatly improved the prognosis of BRAF-mutated melanoma, drug resistance is a major concern even when they are combined with MEK inhibitors. Alternative...
Enregistré dans:
| Publié dans: | Int J Mol Sci |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7835875/ https://ncbi.nlm.nih.gov/pubmed/33478111 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22020976 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|